Alerts will be sent to your verified email
Verify Email
TLL
|
Trident Lifeline
|
Medico Remedies
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
0.14 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
31.52 % | 13.93 % | 6.92 % |
|
5yr average Equity Multiplier
|
2.03 | 2.07 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 1.49 | 0.55 |
|
5yr Avg Net Profit Margin
|
16.21 % | 4.73 % | 8.69 % |
|
Price to Book
|
3.62 | 4.73 | 1.24 |
|
P/E
|
24.91 | 27.24 | 36.14 |
|
5yr Avg Cash Conversion Cycle
|
61.09 Days | 53.33 Days | 49.75 Days |
|
Inventory Days
|
72.84 Days | 48.95 Days | 84.58 Days |
|
Days Receivable
|
86.3 Days | 129.15 Days | 139.4 Days |
|
Days Payable
|
122.66 Days | 124.28 Days | 264.75 Days |
|
5yr Average Interest Coverage Ratio
|
14.53 | 11.55 | 7.03 |
|
5yr Avg ROCE
|
26.3 % | 20.03 % | 10.34 % |
|
5yr Avg Operating Profit Margin
|
16.98 % | 7.11 % | 15.51 % |
|
5 yr average Debt to Equity
|
0.47 | 0.26 | 0.15 |
|
5yr CAGR Net Profit
|
24.36 % | 31.26 % | -11.57 % |
|
5yr Average Return on Assets
|
13.79 % | 6.88 % | 4.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.11 % | 61.38 % | 40.46 % |
|
Share Pledged by Promoters
|
6.77 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.74 % | -11.96 % | -2.75 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Trident Lifeline
|
Medico Remedies
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|